Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-10-16 to 2024-11-06
Current total value of award: $22606.44
Description: 4566132361!XOLAIR 300 MG/2 ML SYRINGE 2ML